EVOLUTE® EXPRESS ABN is a modified PS-DVB polymeric SPE phase for extraction of acidic, basic and neutral analytes. It's unique modified surface structure is water-wettable to promote robust, reliable sample preparation. A balanced combination of polar (hydrophilic) and non-polar (hydrophobic) interactions allows efficient extraction of analytes of wide ranging polarity. Available in a variety of formats, 96-well plates and SPE columns, EVOLUTE EXPRESS ABN is versatile and easy to use for applications ranging from drugs in biological fluids to pharmaceuticals in water.
Part No. | Description | Pack Size | List Price | |
---|---|---|---|---|
600-0010-PX01 | EVOLUTE® EXPRESS ABN 10 mg Fixed Well Plate | 1 | 322 USD | Add to quote/cart |
600-0001-AXG | EVOLUTE® EXPRESS ABN 10 mg/1 mL (Tabless) | 100 | 237 USD | Add to quote/cart |
610-0010-HX | EVOLUTE® EXPRESS ABN 100 mg/10 mL (3 mL XL) | 50 | 236 USD | Add to quote/cart |
610-0010-BXG | EVOLUTE® EXPRESS ABN 100 mg/3 mL (Tabless) | 50 | 254 USD | Add to quote/cart |
610-0015-CXG | EVOLUTE® EXPRESS ABN 150 mg/6 mL (Tabless) | 30 | 198 USD | Add to quote/cart |
600-0030-PX01 | EVOLUTE® EXPRESS ABN 30 mg Fixed Well Plate | 1 | 322 USD | Add to quote/cart |
600-0003-AX | EVOLUTE® EXPRESS ABN 30 mg/1 mL | 100 | 250 USD | Add to quote/cart |
600-0003-AXG | EVOLUTE® EXPRESS ABN 30 mg/1 mL (Tabless) | 100 | 256 USD | Add to quote/cart |
600-0003-AXG-1000 | EVOLUTE® EXPRESS ABN 30 mg/1 mL (Tabless) | 1000 | 2690 USD | Add to quote/cart |
610-0050-CXG | EVOLUTE® EXPRESS ABN 500 mg/6 mL (Tabless) | 30 | 320 USD | Add to quote/cart |
610-0006-BX | EVOLUTE® EXPRESS ABN 60 mg/3 mL | 50 | 174 USD | Add to quote/cart |
610-0006-BXG | EVOLUTE® EXPRESS ABN 60 mg/3 mL (Tabless) | 50 | 174 USD | Add to quote/cart |
Biotage is the Global Go-To Separations Company, supporting customers from drug discovery and development through to diagnostics and analytical testing with intelligent and sustainable workflow solutions. Our expertise and top-tier separation solutions play a key role in streamlining our customers’ workflows and improving their outcomes. Headquartered in Sweden, Biotage operates globally with 700 employees, serving over 80 countries. Our company is listed on NASDAQ Stockholm (BIOT).
Copyright © 2024 Biotage